Edwards Lifesciences Corp’s recently made public that its Director MUSSALLEM MICHAEL A unloaded Company’s shares for reported $2.49 million on May 02 ’24. In the deal valued at $84.77 per share,29,350 shares were sold. As a result of this transaction, MUSSALLEM MICHAEL A now holds 4,486 shares worth roughly $0.38 million.
Then, Lemercier Jean-Luc M sold 14,400 shares, generating $1,212,687 in total proceeds. Upon selling the shares at $84.21, the CVP, EMEACLA and JAPAC now owns 173,849 shares.
Before that, Ullem Scott B. sold 7,250 shares. Edwards Lifesciences Corp shares valued at $622,062 were divested by the CVP, Chief Financial Officer at a price of $85.80 per share. As a result of the transaction, Ullem Scott B. now holds 19,074 shares, worth roughly $1.62 million.
BofA Securities upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in early February from “an Equal weight” to “an Overweight”. Evercore ISI also remained covering EW and has decreased its forecast on January 04, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. Citigroup revised its rating on December 11, 2023. It rated EW as “a Neutral” which previously was an “a Buy”.
Price Performance Review of EW
On Monday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -0.19% to $85.09. Over the last five days, the stock has lost -1.00%. Edwards Lifesciences Corp shares have risen nearly 11.59% since the year began. Nevertheless, the stocks have fallen -3.20% over the past one year. While a 52-week high of $96.12 was reached on 03/28/24, a 52-week low of $60.57 was recorded on 01/04/24. SMA at 50 days reached $89.87, while 200 days put it at $78.43. A total of 2.45 million shares were traded, compared to the trading of 1.94 million shares in the previous session.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 84.60, which if violated will result in even more drops to 84.11. On the upside, there is a resistance level at 85.79. A further resistance level may holdings at 86.49. The Relative Strength Index (RSI) on the 14-day chart is 37.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.12%. Stochastics %K at 23.07% indicates the stock is a holding.
